Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLOFAZIMINE vs CLONAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CLOFAZIMINE vs CLONAZEPAM: Safety Overview

Metric CLOFAZIMINE CLONAZEPAM
Total FAERS Reports 4,433 39,463
Deaths Reported 1,021 8,488
Death Rate 23.0% 21.5%
Hospitalizations 1,528 12,506
Average Patient Age 44.5 yrs 46.0 yrs
% Female Patients 47.1% 58.3%
FDA Approval Date Dec 15, 1986 Approved Prior to Jan 1, 1982
Manufacturer N/A Advagen Pharma Ltd
Route N/A ORAL
Marketing Status Discontinued Prescription